RNAi therapeutics: a potential new class of pharmaceutical drugs
Alnylam Pharmaceuticals (United States)
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
1,082
total citations
- FWCI
- 23.04
- Percentile
- 100%
- References
- 82
Citations per year
Authors
4Topics & keywords
Topics
Keywords
- RNA interference
- Computational biology
- Drug discovery
- Identification (biology)
- Drug
- Biology
- Bioinformatics
- Pharmacology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.